Skip to content

STRAUMANN BONE LEVEL TAPERED IMPLANT SLA Titanium BL (REF 021.3414)Recalls & reported problems

Institut Straumann AG · Bone Level Tapered Implant, D 3.3mm NC, SLA® 14mm, Ti, Loxim™ · Class 2 · Implant

All models of STRAUMANN BONE LEVEL TAPERED IMPLANT (39)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Quick summary

This Straumann Bone Level Tapered implant is a root-form dental implant placed in the jaw to support a replacement tooth. Its 1,606 reports mostly describe the implant failing to bond with the jawbone, with some mentioning pain, scar tissue or infection. The reports include 1,606 injuries and no deaths. No recalls name this device.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
1,635
Deaths reported
0
Injuries reported
1,635
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1,635 adverse event reports that list this exact device (DI 07630031706690), received between Sep 12, 2019 and Sep 28, 2026 — classified as 1,635 injuries.

The most frequently reported specific device problem is “Failure to Osseointegrate” (1,476 reports).

2 other recalls cover devices cleared under the same FDA submission (K140878); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 22 reportsDec 2023: 28 reportsJan 2024: 31 reportsFeb 2024: 34 reportsMar 2024: 22 reportsApr 2024: 35 reportsMay 2024: 23 reportsJun 2024: 31 reportsJul 2024: 38 reportsAug 2024: 20 reportsSep 2024: 33 reportsOct 2024: 24 reportsNov 2024: 40 reportsDec 2024: 33 reportsJan 2025: 37 reportsFeb 2025: 19 reportsMar 2025: 26 reportsApr 2025: 10 reportsMay 2025: 0 reportsJun 2025: 119 reportsJul 2025: 26 reportsAug 2025: 52 reportsSep 2025: 28 reportsOct 2025: 32 reportsNov 2025: 31 reportsDec 2025: 51 reportsJan 2026: 37 reportsFeb 2026: 32 reportsMar 2026: 13 reportsApr 2026: 20 reportsMay 2026: 21 reportsJun 2026: 59 reportsJul 2026: 39 reportsAug 2026: 43 reportsSep 2026: 35 reportsOct 2026: 0 reports202420252026119
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Osseointegrate1,476
  • Loss of Osseointegration142
  • Adverse Event Without Identified Device or Use Problem16
  • Difficult to Insert3
  • Fracture3

Patient problems

  • No Clinical Signs, Symptoms or Conditions1,103
  • Fibrosis325
  • Pain220
  • Unspecified Infection134
  • Inflammation93
  • Swelling/ Edema72
  • Hemorrhage/Blood Loss/Bleeding37
  • Fistula34

Recent adverse event reports

The 25 most recent of 1,635 reports, in the reporter's own words as published by the FDA.

  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50921967 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50921681 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Inflammation

    MAUDE report 50921094 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Inflammation

    MAUDE report 50921093 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Inflammation

    MAUDE report 50921052 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Inflammation

    MAUDE report 50921047 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Inflammation

    MAUDE report 50921024 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Inflammation

    MAUDE report 50921004 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Inflammation

    MAUDE report 50920991 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50920903 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Inflammation

    MAUDE report 50920831 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Fibrosis

    MAUDE report 50920731 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50920220 ↗
  • InjurySep 18, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50825842 ↗
  • InjurySep 18, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2025 in FDI 12. On 2026-07-21, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50825621 ↗
  • InjurySep 18, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50825527 ↗
  • InjurySep 17, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50807552 ↗
  • InjurySep 17, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50807223 ↗
  • InjurySep 17, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50807205 ↗
  • InjurySep 17, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50807183 ↗
  • InjurySep 17, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2025 in FDI 22. On (b)(6) 2026, non-osseointegration was verified. Patient presented with bone type III and fair oral hygiene. The device was forwarded to the manufacturer. At the event the patient experienced: Inflammation. No further patient complications were reported.

    Patient problems: Inflammation

    MAUDE report 50806587 ↗
  • InjurySep 16, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (B)(6) 2026 in FDI 32. On (B)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50792093 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Inflammation

    MAUDE report 50760239 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50759810 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50758487 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K140878. One submission often covers many models, so check the product and lot details in each record.

  • Z-2935-2026 · Jul 16, 2026 · Open, Classified
    Straumann Bone Level Tapered (BLT) Implant, D 4.1mm RC, SLActive 14mm, Roxolid, Loxim (Article 021.5314); implant, endosseous, root-form
  • Z-0117-2015 · Sep 19, 2014 · Terminated
    Straumann Bone Level Tapered Implant 04.1 mm RC, SLActive 8mm, Roxolid, Loxim Article Number: 021 .5308 Dental implants are intended for surgical placement in maxillary and/or man

Other IMPLANT, ENDOSSEOUS, ROOT-FORM devices

All IMPLANT, ENDOSSEOUS, ROOT-FORM devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page